GlassScriptPhysician profile
Nikki Elaine Ford
NPI 1477272656
$627.69
in general payments reported to CMS, 2019-2025
8 companies · $385 in 2025
The $385 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $14.29 · 2024: $228 · 2025: $385.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $608 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $607.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $162.24 | 2024-2025 | Rexulti, Nuedexta |
| Acadia Pharmaceuticals INC | $146.36 | 2024 | Nuplazid |
| Inspire Medical Systems, INC. | $135.04 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $121.84 | 2025 | |
| Eko Health, INC. | $20.00 | 2024 | |
| Tolmar, INC. | $15.85 | 2025 | Jatenzo, Eligard |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.29 | 2023 | Xifaxan |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $12.07 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.